USPTO serial 90361708
BIOLOGY TO BARCODES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- GOODWIN, KATRINA JOYE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOLOGY TO BARCODES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh AUGUSTINE
Leigh AUGUSTINE EIP US LLP4600 S. Syracuse Street, 9th FloorDenver, CO 80237United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for use in genetic research; Assays for research purposes; Assays for testing nucleic acid sequences, antigens, metabolites, bacteria, and viruses, other than for medical or veterinary use; Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemical reagents used for non-medical purposes; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, precursors for in vitro genetic engineering use; Biological preparations for use in industry and science; Biological tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Catalysts for chemical and biochemical processes; Chemical reagents for non-medical purposes; Chemical reagents for non-medical purposes, namely, for use in evaluating nucleic acid sequences, antigens, and metabolites; Chemical reagents, other than for medical or veterinary purpose; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; Chemical test kits for biological samples, biochemical preparations, and waste water for laboratory or research use; Chemicals for use in biotechnological product development; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Enzyme preparations for use in the biotechnology, nucleic acid detection, agricultural, and toxicology industry; Enzyme substrates; Enzymes derived from biotechnological processes for use in industry; Enzymes for scientific and research purposes; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid for laboratory use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Nucleotides for scientific and research use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Reagents for testing biological samples, biochemical preparations, and waste water, other than for medical or veterinary use; Reagents for use in scientific apparatus for chemical or biological analysis; Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use | ACTIVE | Mar 30, 2021 |
| 009 | Automated laboratory equipment mainly for cutting specimens; Computer hardware; Computer hardware for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Computer hardware with preinstalled software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Diagnostic apparatus for testing food; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Digital media, namely, applications and data files featuring software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; DNA chips; DNA microarrays; Downloadable cloud-based software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Downloadable computer software for scientific analysis of genetic sequences; Downloadable computer software for the structural and functional analysis of genomes; Downloadable computer software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways and instructional user guides sold as a unit; Downloadable computer software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways; Downloadable databases in the field of biotechnology, nucleic acid detection, agricultural, and toxicology; Downloadable scientific and medical data via the internet; Downloadable software for dosimetry purposes in the field of radiotherapy; Filters for blood and blood components for laboratory use; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; Hand-operated laboratory tools for manipulating laboratory samples; Laboratory apparatus and instruments for extracting nucleic acids and proteins; Laboratory devices for detecting genetic sequences; Laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; Laboratory robots; Medical laboratory research instruments for detecting the presence of nucleic acid sequences, antigens, gene expression, tissue structures, and radiation exposure; Non-medical imaging devices for nucleic acids and chemical labels; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Scanner for capturing images for analysis for use in the life science research field; Scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; Scientific instrumentation for measuring concentrations of chemicals in water; Scientific instrumentation for measuring the quantity of nucleic acids and antigens, gene expression, and radiation exposure; Scientific instruments, namely, electronic analyzers for measuring, testing and detecting contaminants and environmental pollutants; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of nucleic acid sequences and antigens, gene expression, and radiation exposure; Scientific research specimen collection devices in the nature of bottles, tubes, swabs, syringes, and wipes for the collection of nasal mucus, respiratory droplets, saliva, blood, urine, and feces; Temperature controller for controlling temperature of medical instruments and containers for medical fluids; Testing sample collection equipment, namely, wipes and swabs for use in diagnostic testing, not for medical purposes | ACTIVE | Mar 30, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks owned by BioSpyder Technologies, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Similar marks named BIOLOGY TO BARCODES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 26, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 26, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 20, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 20, 2024 | ALIE | ASSIGNED TO LIE | — |
| Sep 19, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jun 10, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Mar 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2024 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 14, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 24, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jan 24, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 3, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 31, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 31, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 29, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 29, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 3, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 3, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |